Share This Post

Cabozantinib improves outcomes for patients without reducing quality of life

Read more here: http://news.feinberg.northwestern.edu/2018/02/evaluating-quality-of-life-after-kidney-cancer-treatments/

Share This Post

Dena Battle is the President of KCCure. She also serves on the Advisory Board for the Johns Hopkins Sidney Kimmel Cancer Center and as a member of the Patient and Family Advisory Council.

Lost Password

Register

Subscribe for updates!